Buy BDPARP Olaparib 150 MG Tablets Online – Trusted Cancer Medicine Exporter in India.

BDPARP Olaparib 150 MG Tablets

BDPARP Olaparib 150 MG Tablets is a targeted anti-cancer medication used in the treatment of specific types of cancers, particularly those associated with BRCA gene mutations. It belongs to a class of drugs known as PARP inhibitors (Poly ADP-Ribose Polymerase inhibitors), which work by preventing cancer cells from repairing their damaged DNA, ultimately leading to cell death.

Olaparib is widely used in modern oncology as a precision therapy, especially for ovarian, breast, pancreatic, and prostate cancers. It helps slow disease progression and, in many cases, improves survival outcomes when used as maintenance therapy after chemotherapy.

📞 Contact Details to Place Order

💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com

Composition and Content

Active Ingredient: Olaparib
Strength: 150 mg per tablet
Formulation: Film-coated oral tablets
Class: PARP Inhibitor (Targeted Therapy)

How to Use

Take the tablet orally with or without food, as prescribed by your oncologist.
Swallow whole with water; do not crush, chew, or split the tablet.
Maintain a consistent schedule for best results.
Avoid grapefruit or Seville oranges during treatment, as they may interfere with the drug.

Dosage

The typical recommended dose is 300 mg twice daily (two 150 mg tablets per dose).
Dosage may vary based on:
- Patient condition
- Tolerance and side effects
- Doctor’s clinical judgment
Always follow your healthcare provider’s instructions strictly.

Uses

BDPARP Olaparib 150 MG Tablets are used in the treatment of:

Ovarian cancer (maintenance therapy in BRCA-mutated cases)
Breast cancer (HER2-negative with BRCA mutation)
Pancreatic cancer (metastatic with BRCA mutation)
Prostate cancer (metastatic castration-resistant cases)

Treatments & Mechanism of Action

Olaparib targets cancer cells by inhibiting the PARP enzyme, which is crucial for DNA repair. Cancer cells with BRCA mutations already have compromised DNA repair mechanisms. By blocking PARP:

DNA damage accumulates in cancer cells
Cancer cells cannot repair themselves
This leads to selective cancer cell death while sparing healthy cells

Advantages

Targeted therapy with precision action
Improves progression-free survival
Oral administration (no hospitalization required)
Effective in BRCA-mutated cancers
Can be used as maintenance therapy

Storage Conditions

Store at room temperature (20°C–25°C)
Keep away from moisture and direct sunlight
Store in original packaging
Keep out of reach of children

Alternative Indian Brands for Olaparib 150 MG Tablets

Some commonly available Indian alternatives include:

Olanib 150 mg Tablets (by Natco Pharma)
Olaparix 150 mg Tablets (by Beacon Pharmaceuticals)
Lynparza 150 mg Tablets (by AstraZeneca – innovator brand)
Olapib 150 mg Tablets (various Indian manufacturers)

These alternatives may vary in price and availability but contain the same active ingredient Olaparib.